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Golgi & ERES Biogenesis in the Malaria-Causing Parasite Plasmodium falciparum
Michelle Morales, Susann Herrmann and Tim-Wolf Gilberger, Bernhard Nocht Institute for Tropical
Medicine, Hamburg, Germany. Sponsored by Choukri Ben Mamoun, Department of Internal Medicine,
Yale University School of Medicine, New Haven, CT.

Plasmodium falciparum, the parasite causing the most severe form of human malaria,
continues to bear a global burden of morbidity and mortality. No vaccine is available and
resistance is emerging and expanding to all classes of existing antimalarials. Relatively
little is known about the secretory pathway of P. falciparum, which has the ability to
export proteins to specialized parasite organelles and into the host erythrocyte to create
the ideal environment for growth.
This thesis is focused on an understanding of the biogenesis of two critical organelles
within P. falciparum’s secretory pathway: endoplasmic reticulum exit sites (ERES) and
the Golgi apparatus. This study cloned parasites containing fluorescently-labeled proteins
to identify ERES (Sec13p) and the Golgi apparatus (GRASP). Time lapse 3D
microscopy, photobleaching and photoconversions were used to visualize the process.
In this thesis, it was shown that Plasmodium falciparum ERES undergo recruitment at
rapid rates of approximately 15.2 seconds following photobleaching experiments.
Evidence gathered via time-lapse microscopy in conjunction with photoconversions of
Sec13p fused to Dendra showed that ERES form de novo. Although conclusive evidence
on Golgi biogenesis was not obtained, given the close spatial and duplication time
relationship between ERES and the Golgi and previous studies in Pichia pastoris and
Trypanosoma brucei, it is speculated that the Golgi similarly forms de novo. Strides were
made towards the creation of a GRASP knock-out and examination of GRASP
interaction partners in P. falciparum, which after optimization of methods, may allow for
a more detailed study of Golgi biogenesis, GRASP affect on Golgi architecture and on
alternative secretion of proteins. It is hoped these conclusions will further the
understanding of the P. falciparum secretory pathway, which may ultimately lead to
novel drug targets in the fight against malaria.
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Introduction
Malaria Past and Present
Malaria has been a global burden for centuries, possibly millenniums. Clay tablets in
Mesopotamia dated to 2000 B.C. and Papyri in Egypt dated to 1570 B.C. contained
references to what is almost certainly the disease1. The beginning of modern knowledge
on malaria pathogenesis occurred about 130 years ago when Charles Louis Alphonse
Laveran, a French physician stationed in a military hospital in Algeria, discovered
parasites in the blood of a recently diseased malaria patient 2.

Since that time, disease patterns have significantly changed, in large part due to efforts
toward prevention, eradication, detection and treatment. The World Health Organization
(WHO) implemented the WHO Global Malaria Eradication Programme in 1955,
spearheading the use of chloroquine for malaria prophylaxis and treatment plus
dichlorodiphenyltrichloroethane (DDT) for vector control 3. In part due to loss of political
and financial support, the goal of global eradication was abandoned in the early 1970s; at
the same time a surge of malaria cases in sub-Saharan Africa, exacerbated by
chloroquine-resistant malaria and DDT-resistant Anopheles mosquito vectors, was
noticed 3.

In spite of setbacks resulting from parasite and vector adaptation, promising trends in
global recession have been observed. In 1900, it is estimated that 58% of the Earth’s land
surface was malaria endemic, compared with 30% in 2007; the decrease was mainly
attributed to economic development and prevention strategies 4.
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Nonetheless, sub-Saharan Africa is overwhelmed with malaria to this day, with
temperatures and environmental factors playing a huge role in the existence of the
disease. In temperate climates, the malarial reproduction rate is drastically lower than in
the tropics, with malarial development ceasing all-together below 16 degrees Celsius 5.
Poverty complicates the situation, with poor housing providing inadequate protection
from mosquitoes, prohibitive costs rendering insecticide-treated bed nets inaccessible and
low levels of literacy and education leading to decreased knowledge of malaria
prevention and symptom recognition 6. The cycle worsens when you consider the high
rate of malarial infection in pregnant women, partially secondary to decreased immunity
in the gravid state. Malaria greatly increases the risk of delivering a low birth weight
infant, who is known to have a significant risk of neuro-cognitive delay, with a two-tofour fold increased likelihood of failing school 5.

The World Malaria Report 2010 reported an estimated 225 million cases of malaria
worldwide in 2009, down from 244 million in 2005 7. The biggest decrease in incidence
during the four year period occurred in Europe and the Americas. Africa carried the
burden of the disease, with 78% of cases and 91% of deaths 7. There was also a decline in
worldwide malarial deaths from 985,000 in 2000 to 781,000 in 2009, but 85% of these
deaths occurred in one of the most vulnerable sections of society, children under five
years of age 7.

Plasmodium Variations

The eukaryotic genus Plasmodium is responsible for malaria, a mosquito-borne disease.
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Plasmodium is a member of the phylum Apicomplexa, a large group of approximately
five thousand obligate intracellular protozoan parasites that also includes the humandisease causing organisms Cryptosporidium, Babesia and Toxoplasma 8. Many species of
Plasmodium have been characterized, including several strains recently discovered in
African apes – one of which is believed to be the immediate precursor to Plasmodium
falciparum 9. However, only four species are known to routinely infect humans; these
include Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale and Plasmodium
malariae 10. A fifth species, Plasmodium knowlesi, was previously believed to infect only
long-tailed macaque monkeys, but has been shown to naturally infect humans in
Southeast Asia, particularly Malaysia 11.

These species vary in pathogenesis and severity. P. vivax and P. ovale have the ability to
form inactive hypnozoites which can remain dormant in the liver for months to years,
although the existence of hypnozoites in P. ovale is now debated

3, 12

. The activation of

dormant hypnozoites can lead to a relapse of malaria, making these species difficult to
eradicate

13

. P. vivax can also lead to severe anemia (Hemoglobin less than 5g/dl),

particularly in children, and lung injury from inflammatory increases in alveolar-capillary
permeability

14, 15

. P. malariae does not form hypnozoites, but can persist for decades as

an asymptomatic blood infection 3. P. falciparum is the most virulent and deadly form,
and the subject of this research. It has an ability to modify the surface of host red blood
cells with knobs that can adhere to vascular endothelium, leading to occlusion in organs
such as the brain (leading to cerebral malaria) or placenta (one in four women in SubSaharan Africa has evidence of placental infection at the time of delivery) 16, 17.

8
Plasmodium falciparum Life Cycle

During the blood meal of a female Anopheles mosquito, Plasmodium sporozoites can be
injected into the human dermis and enter the blood stream. From there, sporozoites are
carried to the liver and cross through liver macrophages, Kupffer cells, into hepatocytes 3.
In the hepatocytes, infective merozoites are formed via massive asexual replication.
These hepatic merozoites reach the blood stream by inducing host cell death and
detachment, while simultaneously inhibiting exposure of phosphatidlyserine (a
phagocytic signal) on the host plasma membrane, thereby ensuring self-protection from
host immunity 18.

Once blood-borne, P. falciparum merozoites can invade any erythrocyte. Invasion is a
complicated process that begins with the recognition of red blood cell (RBC) surface
receptors over a long distance. This is followed by reorientation of the parasite’s apical
end to the erythrocyte surface, formation of a tight junction with a high affinity ligandreceptor interaction, invasion of the erythrocyte by the parasite’s actin-myosin motor,
shedding of the parasite’s surface coat by a serine protease with concurrent formation of a
parasitophorous vacuole (a compartment that surrounds the parasite and allows further
maturation), and finally resealing of the RBC membrane 19.

The invasion process was at the forefront of the search for a vaccine against malaria.
Apical Membrane Antigen 1 (AMA-1), a micronemal protein of apicomplexan parasites
that is believed to be essential for invasion, was a promising candidate, eliciting immune
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responses that inhibited parasites in vitro and in animal models. Unfortunately, the
polymorphic nature of the antigen greatly decreased vaccine efficacy in human trials 20.

Invasion begins the forty eight hour asexual life cycle. Upon invasion, the former
merozoite is now termed ring stage. This ring-stage parasite lasts approximately twenty
two hours. During the ring stage, host-cell remodeling, such as formation of knobs on the
infected red blood cell (iRBC) surface for endothelial adhesion and formation of
Maurer’s clefts for protein trafficking, takes place 21, 22. The parasite also begins ingesting
hemoglobin for an energy source, creating haemozoin as a byproduct. The parasite then
transitions to a trophozoite stage, during which growth continues and DNA replication
begins. At 36 hours post-infection, the trophozoite matures to a schizont-stage parasite.
This stage is characterized by nuclear division, leaving 8-32 new nuclei in the parasite.
Cell division results in 32 mono-nucleated merozoites. The iRBC then bursts, releasing
free merozoites into the blood stream to infect new erythrocytes 23. This asexual life cycle
is the cause of symptoms, such as cyclical fever, associated with malarial disease.

Some parasites in the asexual, blood-stage cycle develop into gametocytes, or sexual
forms that can be taken up by female Anopheles mosquitoes during subsequent blood
meals. Male and female gametocytes meet in the mosquito midgut, resulting in
fertilization and subsequent development until new P. falciparum sporozoites are formed
and reach the mosquito salivary gland, where they can be injected into human skin,
repeating the infection cycle 3.

Secretory Pathway of Proteins
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An endoplasmic reticulum (ER), endocytic organelles and a plasma membrane are
features of all known eukaryotic cells. Although the conservation of secretory apparatus
and protein targeting sequences can be traced as far back as amebae on the evolutionary
tree24, the emergence of such a system is generally considered to be a crucial stage in the
transition from prokaryotic to eukaryotic organisms25.

Within the secretory pathway, the ER is the site of translocation, integration, protein
folding and modification, and phospholipid and steroid biosynthesis26; it is in close
association with the cell nucleus27. The ER can be divided into three distinct regions:
rough ER, smooth ER, and transitional ER. The rough ER is so named because of its
texture, stemming from the presence of ribosomes in all cells synthesizing proteins28. The
smooth ER is the site of lipid biosynthesis29. The transitional ER (also named ER exit
sites, or ERES as used in this thesis) are sites of protein exit from the ER30.

The ERES, characterized by the presence of COPII vesicle components, are regions that
export proteins to the Golgi apparatus31. Cop II coated vesicles contain two protein
complexes (Sec23p/Sec24p and Sec13p/Sec31p) and the GTPase Sar1p32. Recently, it has
been shown that Sec13p ridigidfies the COPII vesicle and influences membrane
bending33. The cytosolic components arrange themselves at ERES to transport cargo to
the Golgi apparatus. Numerous components of COPII-mediated transport have been
identified in P. falciparum, including Sec13p, used as an ERES marker34. ERES
morphology has also been shown to have a relationship with the morphology of the Golgi
apparatus. In Pichia pastoris, ERES are well defined and in close approximation with the
cis-Golgi; the Golgi apparatus is a classically stacked structure in this organism35. In
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contrast, Saccharomyces cerevisae demonstrates COPII vesicle components along the
entire ER membrane; the Golgi in this organism is unstacked and scattered throughout
the cytoplasm35. In P. falciparum, ERES (as visualized with the ERES marker Sec13p),
are noted to be defined, restricted areas of the ER membrane in close association with the
Golgi36.

The Golgi apparatus is one of the most important organelles in the secretory pathway,
functioning as a processing, sorting and protein modification center26. The Golgi is
believed to undergo continuous remodeling, stemming from protein transport via ERES37.
Golgi can vary widely in morphology between organisms38, but generally consists of a
cis-Golgi, medial region and trans-Golgi. The cis-Golgi acts as the docking site for
COPII-coated vesicles containing proteins from ERES, as well as the site of COPI vesicle
budding (important for retrograde transport from Golgi to ER), while the trans-Golgi is a
major sorting station for the secretory pathway and the “crossroads of the endocytic and
exocytic pathways” 39, 40.

P. falciparum lacks some protein modification abilities, in particular N glycosylation41,
but does possess a Golgi apparatus. The Golgi is not stacked, is singular early in the
parasite life cycle and duplicates prior to nuclear division and continues to duplicate until
each progeny has its own singular Golgi prior to the bursting of infected red blood cells
and release of merozoites42. The Golgi also has distinct cis- and trans-Golgi in close
connection, but spatially separated as parasite maturation occurs36. How the Golgi
duplicates in P. falciparum has not been proven. In Trypanosoma brucei, the Golgi also
begins as a singular entity early in the life cycle before a new Golgi emerges de novo and
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in close proximity to the ERES43,

44

. In contrast, Toxoplasma gondii performs Golgi

duplication via lateral extension followed by medial fission45.

Golgi Re-Assembly and Stacking Protein (GRASP)

The Golgi Re-Assembly and Stacking Proteins (GRASPs) were discovered over ten years
ago as proteins anchored to the Golgi membrane which participate in membrane tethering
events and provide structural support to Golgi architecture46. The proteins are found in
most eukaryotes and are generally encoded as a single copy in genomes. In vertebrates, a
gene duplication event led to two proteins, GRASP65 and GRASP55, varying in location
(cis-Golgi for GRASP65 and medial Golgi for GRASP55), interaction partners and
molecular weight47. Both proteins contain a highly conserved N-terminal domain, an Nterminal membrane attachment motif and a divergent C-terminus enriched in serine and
proline48. This C-terminus is the site of phosphorylation leading to unstacking of the
Golgi at mitosis followed by dephosphorylation leading to restacking; it also serves as a
substrate for caspases during apoptosis49.

Although GRASPs are believed to play a crucial role in the stacking of Golgi cisternae, it
was not understood why some organisms possessing copies of GRASP do not have
stacked Golgi. Interestingly, a GRASP knock-out in Disctyostelium discoideum did not
have an effect on Golgi architecture, but did prevent transport of the protein AcbA50, 51.
These findings raised questions of whether GRASP was involved in alternative secretion
of proteins. The findings have been duplicated in the yeast Pichia pastoris, suggesting a
pathway for alternative secretion may have been evolutionarily conserved52.
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In P. falciparum, GRASP (which is used to visualize the Golgi) posses a splice variant
that leads to the expression of two GRASP isoforms, termed GRASP1 and GRASP2,
located at the cis-Golgi. GRASP2 differs at its N-terminus, possessing a region similar to
that of fungi GRASP42. Since P. falciparum does not have a stacked Golgi, but has two
isoforms of GRASP, it has been postulated that GRASP is more important for alternative
secretion in the parasite. P. falciparum generally utilizes a PEXEL (Plasmodium
falciparum EXport ELement) motif consisting of the amino acids R/KxLxE/QD, where x
represents any amino acid to mark proteins destined for export53. However, PEXELnegative exported proteins, or PNEPs lacking the motif exist and the number identified
continues to grow54. A link between PNEP export and GRASP may lead to understanding
this alternate pathway.

Current Drug Options and Resistance

Current antimalarials work at different stages of the parasite life cycle, with nearly all
having a method of action during the asexual blood stages55. Drugs currently available to
treat malaria can be classified based on known methods of action. Nucleic acid inhibitors,
including sulfonamides and sulfines in type 1 and pyrimethamines, trimethoprim and
biguanides, such as proguanil, in type 2, act to inhibit the folate pathway, ultimately
decreasing DNA synthesis56. These drugs are susceptible to mutations at binding sites.
Napthoquinones, such as atovaquone, similarly inhibit nucleic acid formation, and have
demonstrated resistance at conenzyme Q binding sites57. Haem detoxification drugs, such
as the type 1 quinoline chloroquine and the type 2 quinolines quinine and mefloquine,
have a method of action that is still not completely known, but likely involves buildup of
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Haem in the parasite food vacuole; resistance is multi-gene and complex in nature55.
Finally the artemisinin-type compounds are believed to act by oxidative stress, releasing
free radicals via a still debated mechanism58. Frighteningly, evidence of resistance,
particularly along the Cambodia-Thailand border, has been emerging to the artemisinins
which are widely considered one of the most powerful weapons against malaria59.

Summary

Plasmodium falciparum is a disease with an unbalanced burden towards poverty-stricken
countries. It remains one of the greatest causes of morbidity and mortality worldwide,
particularly in children under five years of age. There remains no vaccine and resistance
to existing drug regimens exists and is expanding, with the last major class of
antimalarials being introduced more than fifteen years ago60.

The parasitic life style of P. falciparum relies on complicated protein transport machinery
to shuttle proteins to specialized organelles, such as the apicoplast61, and perhaps more
intriguingly to export proteins into its host cell, transversing multiple membrane barriers
to allow for the remodeling of the infected red blood cell into the ideal living
environment62, 63.
In the past, investigations into protein transport machinery and in particular the secretory
pathway have yielded natural molecules that disregulate membrane traffic by enhancing
retrograde transport through the endoplasmic reticulum, such as brefeldin A64, result in
Golgi vesiculation by binding Golgi membranes, such as norrisolide65,

66

, or result in

Golgi fragmentation, such as macfarlandin E67. In addition, novel synthetic small
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molecules, such as secramine, have been found to possess the ability to disrupt the
secretory pathway68, 69.

These findings open the door to the discovery of molecular targets for disease, which
have already begun to find a place in clinical practice. For example, there have been trials
of the mammalian target of rapamycin against breast cancer70. The effects of the
aforementioned Golgi-disrupting substances on P. falciparum have not been closely
studied. Yet, libraries of potential drug targets within the secretory pathway of P.
falciparum exist60.

Promisingly, the understanding of the protein export continues to improve. For instance,
the existence of a translocon to facilitate the export of proteins across the parasitophorous
vacuole membrane and the parasite’s ability to alter the erythrocyte plasma membrane’s
permeability by creating new permeation pathways or upregulating existing ion
channels71 reveals hopeful insight. The expansion of knowledge on alternative secretion
of proteins, which may be connected to GRASP, could provide answers to the puzzle of
PNEP secretion.

A more basic understanding of the secretory pathway, including information on the
biogenesis of crucial organelles such as the Golgi apparatus and ERES in P. falciparum is
lacking. This essential piece of information is the main subject of this thesis. Such
knowledge would hopefully translate into the ability to better select drug targets along the
secretory pathway, which may lead to new hope in the fight against malaria.
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Statement of Purpose

Hypothesis

The Golgi and endoplasmic reticulum exit sites (ERES) in Plasmodium falciparum, as
visualized by the marker proteins GRASP1, GRASP2 and Sec13p, are formed de novo
rather than splitting from existing organelles.

Specific Aims

1. To create and analyze constructs forming Plasmodium falciparum parasites that
express the fluorescent tags Dendra or GFP attached to the Golgi marker proteins
GRASP1 or GRASP2 or the ERES marker protein Sec13p.

2. To examine Golgi and ER exit site biogenesis via time-lapsed 3D confocal microscopy
concentrating on signal changes in photobleached or photoconverted Plasmodium
falciparum parasites expressing the marker proteins GRASP1, GRASP2 or Sec13p along
with the fluorescent tags GFP or Dendra

3. To attempt a conditional protein degradation of GRASP1 and GRASP2 utilizing a
destabilization domain (DD) and the stabilizing ligand Shld1 in conjuction with the
fluorescent tag GFP
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Methods
Molecular Cloning of Constructs

The constructs Grasp1pARLDD and Grasp2pARLDD, which were used for attempted
conditional protein degradation, were based on the constructs Grasp1pARLGFP and
Grasp2pARLGFP (Gilberger lab). Midipreps of Grasp1pARLGFP and Grasp2pARLGFP
were each digested with the restriction enzymes AvrII and XhoI for 2 hours at 37ºC in the
presence of BSA and NEB Buffer 4 (reagents from New England BioLabs). This created
the vectors Grasp1pARL and Grasp2pARL. The destabilization domain (DD) was
amplified via polymerase chain reaction (pcr) from a miniprep of DD in the vector
pHCAM (Gilberger lab), using the primers DD Sense and DD Antisense (see Table 1).
The pcr product was purified with the Macherey-Nagel NucleoSpin Extract II kit and
subsequently digested with AvrII and XhoI as detailed above. The digested vectors and
the digested insert were again kit-purified and subsequently ligated for 1 hour at room
temperature using New England BioLabs T4 DNA Ligase and Ligase Buffer. The
ligation products were incubated in electrocompetent XL-Gold E.Coli cells (Gilberger
Lab), on ice for 20 minutes. The cells were then heat shocked at 42ºC for 30 seconds and
immediately placed on ice for 10 minutes. LB was added to each transformation product,
which was then incubated at 37ºC, 900 rpm for 45 minutes. The product was then
centrifuged at room temperature, 13,200 rpm for 1 minute. The supernatant was
discarded and the pellet was smeared onto an LB-Ampicillin plate, which was incubated
at 37ºC overnight. Colonies were picked from the plate and screened via colony pcr using
the primers DD Sense and DD Antisense to ensure the correct insert (DD) was present.
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Selected colonies were grown up in 2mL tubes with LB-Ampicillin overnight. Minipreps
were then performed using the Macherey-Nagel Nucleospin Plasmid kit. Miniprep
products were subsequently digested with KpnI (restriction site located between the CRT
promoter and Grasp1/Grasp2 in the pARL vector) and XhoI at 37ºC for 1 hour in the
presence of FastDigest Buffer (reagents from Fermentas). This served as a second check
for the presence of the correct insert. Minipreps that were adequately digested were sent
for sequencing using DD Sense and DD Antisense Primers (Seqlab Sequence
Laboratories Göttingen, Germany). Minipreps showing proper sequences were grown up
in 100mL LB-Ampicillin overnight and amplified with the Qiagen Plasmid Midi kit.

The constructs Grasp1pARLGFPDD and GRASP2pARLGFPDD were created with the
Grasp1pARL or Grasp2pARL vector, construction described above. The insert, GFPDD,
was created by first amplifying GFP using the primers GFP Sense Overlap and GFP
Antisense Overlap (Table 1), thereby inserting a 3' PstI restriction site. DD was then
amplified using the primers DD Sense Overlap and DD Antisense Overlap (Table 1),
which added a 5' PstI site. The two pcr products were mixed and amplified again using
the primers GFP Sense Overlap and DD Antisense Overlap to create the final insert,
which was subsequently purified and digested with XhoI and AvrII prior to ligation with
either vector. Constructs were screened and sequenced as described above.

The constructs Grasp1pARLDendra, GRASP2pARLDendra and Sec13ppARLDendra
were created with the vectors Grasp1pARL, Grasp2pARL (construction described above)
and Sec13ppARL (Gilberger lab). The insert, Dendra (courtesy of C. Grüring), was
amplified via pcr using the primers Dendra Sense and Dendra Antisense (Table 1) and
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subsequently purified and digested with XhoI and AvrII prior to ligation with the
corresponding vector.

Similarly, the construct Grasp1pARLTapTag was created with the vector Grasp1pARL.
The insert, TapTag (Gilberger lab), was amplified via pcr using the primers Tap Sense
and Tap Antisense (Table 1) and subsequently purified and digested with XhoI and AvrII
prior to ligation with the Grasp1pARL vector.

The construct Grasp1DDpHCAM3xHA was created using the vector pHCAM3xHA
(Gilberger lab) digested with the restriction enzymes PstI and NheI (New England
BioLabs) at 37°C for 2 hours. The insert, Grasp1(last 1000bp)DD, was amplified via pcr
using the construct Grasp1pARLDD, construction detailed above, and the primers
Grasp1DD Sense for pH3xHA and Grasp1DD Antisense for pH3xHA (Table 1). The pcr
product was subsequently purified and digested with PstI and NheI prior to ligation with
the pHCAM3xHA vector.

Plasmodium falciparum Parasite Culture and Transfection

P. falciparum cultures were maintained at 5 % hematocrit in 5mL or 10mL Petri dishes.
RPMI-1640 complete medium was used as culture medium. The medium was exchanged
every other day. The parasites were cultivated in erythrocytes of blood group 0+ in a gas
environment of 5 % O2, 5 % CO2 and 90 % N2 at 37 °C. To estimate culture parasitemia,
thin smears were prepared and air dried, followed by fixation in methanol for 1 min and
staining in Giemsa solution (1:10 diluted stock solution) for approximately 20 min.
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Parasitemia was then estimated using light microscopy. Cultures were diluted when
parasitemia reached approximately 10%.

Table 1: DNA primers used in this study. All primers were designed by M. Morales in
collaboration with S. Herrmann, unless otherwise noted. Asterisk indicates primers
designed by C. Grüring. Restriction enzyme sequences are underlined. Custom DNA
oligonucleotides were synthesized by Sigma-Aldrich.
Primer Name

Sequence (5’-3’)

Purpose

Restriction
Enzyme

DD Sense

GCGCCCTAGGGGAGTGCA
GGTGGAAACCATCTCC

Amplify DD for Grasp1pARLDD and Grasp2pARLDD

AvrII

GCGCCTCGAGTTAATGCATG Amplify DD for Grasp1pARLDD and Grasp2pARLDD
GCCATGGCCAGGTCCTC
GFP Sense
GCGCCCTAGGATGAGTA
Amplify GFP-DD for Grasp1pARLGFPDD and
Overlap
AAGGAGAAGAACTTTTC
Grasp2pARLGFPDD
GFP Antisense GGAGATGGTTTCCACCTGCA Amplify GFP-DD to create Grasp1pARLGFPDD and
Overlap
CTCCCTGCAGTTTGTATAGT
Grasp2pARLGFPDD
TCATCCATGCC
DD Sense
GGCATGGATGAACTATACA Amplify GFP-DD to create Grasp1pARLGFPDD and
Overlap
AACTGCAGGGAGTGCAGGT
Grasp2pARLGFPDD
GGAAACCATCTCC
DD Antisense
GCGCCTCGAGTTAATGCAT
Amplify GFP-DD to create Grasp1pARLGFPDD and
Overlap
GGCCATGGCCAGGTCCTC
Grasp2pARLGFPDD
Dendra
GCGCCCTAGGATGAAC
Amplify Dendra tocreate Grasp1pARLDendra,
Sense*
ACCCCGGGAATTAACC
Grasp2pARLDendra andSec13ppARLDendra
Dendra
GCGCCTCGAGTTACCAC
Amplify Dendra to create Grasp1pARLDendra,
Antisense*
ACCTGGCTGGGCAGGG
Grasp2pARLDendra and Sec13ppARLDendra
Tap Sense
GCGCCCTAGGTCCATG
Amplify TAP Tag to create Grasp1pARLTAPTag
GAAAAGAGAAGATGG
Tap Antisense GCGCCTCGAGTCAGGTTGA
Amplify TAP Tag to create Grasp1pARLTAPTag
CTTCCCCGCGGAATTCGC
Grasp1DD Sense GCGCCTGCAGAAGTGAAT
Amplify Grasp1(last 1000bp)DD to create
for PH3xHA
CTAACAATTATAAAAAGG
Grasp1DDpHCAM3xHA
Grasp1DD
GCGCGCTAGCATGCATG
Amplify Grasp1(last 1000bp)DD to create
Antisense for
GCCATGGCCAGGTCCTC
Grasp1DDpHCAM3xHA
PH3xHA

XhoI

DD Antisense

AvrII
PstI

PstI

XhoI
AvrII
XhoI
AvrII
XhoI
PstI
NheI

To transfect constructs into P. falciparum parasites, 3D7 wild-type parasites were
cultivated to a parasitemia of approximately 10%. Cultures consisting of predominantly
young ring stage parasites were synchronized by first centrifuging the culture at 800xg
for 5 minutes and discarding the supernatant. The packed red cell pellet was then
resuspended in 5% sorbitol in distilled water and incubated at 37°C for 10 minutes. The
cells were centrifuged again at 800xg for 5 minutes and washed with RPMI-1640
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complete medium. The pellet was then resuspended in 800µL of cytomix (120mM KCl,
0.15mM CaCl, 2mM EGTA, 5mM MgCl2, 10mM K2HPO4 and 25mM Hepes, pH 7.6).
This was mixed with 100µg of construct plasmid DNA from a midiprep (precipitated
with sodium acetate and 100% ethanol) and transferred to an electroporation cuvette.
Electroporation was performed using a Bio-Rad gene pulser set at 200Ω. The pulse
controls were set to 2.5kV and 25µF with time constants of 0.7-0-9ms. Following
electroporation, samples were mixed with 10mL of RPMI-1640 complete medium and
placed in a Petri dish. Transfectants were selected using 10nM WR 99210. In addition,
constructs containing the destabilization domain (DD) were split following transfection,
with half of the culture maintained with Shld1 and the other half without, as a means of
control. Culture media and selection agents were changed every day for 10 days
following transfection and then every other day. Transfectants were obtained after an
average selection period of 5 weeeks.

Frozen stocks of all constructs of P. falciparum parasites created were prepared for long
term storage. Ring stage cultures with a parasitemia of approximately 10% were
subjected to centrifugation at 800xg for 10 minutes. The supernatant was removed and
the packed red cells were washed once in RPMI-1640 complete medium. Then 1.5mL of
malaria freezing solution (containing 28% glycerol, 3% sorbitol, 0.65% sodium chloride
and distilled water) was used to resuspend the pellet. The samples were placed in
cryotubes and transferred a liquid nitrogen tank.

Western Blots
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Samples of P. falciparum cultures were prepared by adding 1mL of 0.1% saponin to
cultures with a parasitemia of approximately 10%, followed by centrifugation at 6000rpm
for 10 minutes, 3 washes with 1xPBS and resuspension in 1xSDS running buffer
(1%SDS, Tris and glycine). Samples were again centrifuged and the supernatant was
removed, resulting in a parasite pellet. This was resuspended in 30µL of resuspension
buffer and 5µL of reducing dye was added. The sample was heated at 50°C for 10
minutes and centrifuged at 13000rpm for 10 minutes. The supernatant was used for SDSPAGE, with 7% polyacrylamide gels (Gilberger lab). The proteins were separated for
approximately 20 minutes at 120V.

The SDS-PAGE gels containing the proteins of interest were transferred to nitrocellulose
membranes (Schleicher & Schüll) using 10 mM CAPS pH 11.2 transfer buffer without
methanol and a tankblot device (Bio-Rad). Blocking of free protein was done using 5%
milk in 1xPBS for 30 minutes. The primary antibody, rabbit α-P. falciparum GRASP
(Gilberger lab), was added in a 1:1000 dilution in 5% milk at 4°C overnight. The
membrane was then washed twice with 1xPBS. The membrane was blocked with a
secondary HRP-coupled sheep α-rabbit antibody (Sigma) in a 1:2500 dilution in 5% milk
at room temperature for 2 hours. The membrane was again washed 2 times with 1xPBS
and incubated with ECL (GE Healthcare). Chemiluminescent signal was then visualized
by exposure of X-ray films.

Chelex PCR
To create the templates for Chelex pcr, 5-10µL of P. falciparum culture with a
parasitemia of 10% was obtained and 200µL of chelex resin (Bio-Rad) was added. This
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was incubated on a shaker at 60°C, 700rpm for 30 minutes. The sample was then
incubated in a hot water bath at 90°C for 10 minutes and then instantly placed on ice for
10 minutes. The sample was centrifuged at 13000rpm for 1 minute. The supernatant was
used as the template for pcr, using primers (Table 1) originally used for creation of the
construct at interest.

Fluorescence Microscopy and Immunofluorescence Assays

To image the fluorescence in live, unfixed parasites, approximately 50 µL of P.
falciparum culture was collected from the bottom of culture dishes. If appropriate, this
was incubated with 1 µg ml-1 DAPI, 4′,6-Diamidine-2′-phenylindole dihydrochloride,
(Roche) for 15 minutes at 37°C to image the parasite nucleus. Thin smears on glass slides
were then prepared. Images were observed and recorded using a Zeiss Axioscope M1
microscope equipped with a 100×/1,4 oil immersion lens coupled with a Hamamatsu
Orca C4742-95 camera and Zeiss Axiovision software.

To perform an immunofluorescence assay, a packed red cell pellet was obtained from P.
falciparum cultures with a parasitemia of 10%. 1mL of fixing solution (4%
formaldehyde, 0.0075% glutaraldehyde, 10xPBS and double distilled water) was added
and allowed to incubate for 30 minutes at room temperature. The sample was then
centrifuged at 3000rpm for 2 minutes. The supernatant was discarded and the pellet was
washed 3 times with 1xPBS. To permeabilize the membrane, the pellet was resuspended
in 1mL of 0.1% Triton in PBS, incubated for 10 minutes at room temperature and washed
3 times with PBS. The sample was then blocked with 3% BSA/PBS for 1 hour at room
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temperature and then centrifuged at 3000rpm for 2 minutes. The supernatant was
discarded and 500µL of the primary antibody (rabbit α-BiP in a 1:2000 dilution,
Gilberger lab) was added in 3% BSA/PBS. The sample was incubated at room
temperature for 1 hour on a roller and washed 3 times with 1xPBS. The secondary
antibody (Alexa-Fluor-594 goat α-rabbit IgG antibody in a 1:2000 dilution, Molecular
Probes) was added to samples in aluminium foil-wrapped tubes and incubated for 1 hour
on a roller at 4°C. DAPI was then added in a 1:4000 dilution to visualize the nucleus. The
sample was washed 3 times for 10 minutes each with 1xPBS. Fluroescence was
visualized as described above.

Confocal Microscopy, Photobleaching and Photoconversions

To check fluorescence and obtain 3D reconstruction images and movies, approximately
50µL of live Plasmodium falciparum culture was obtained and, if appropriate, incubated
with DAPI as described above. Thin smears on glass slides were then prepared. Parasites
were imaged at room temperature using an Olympus FV1000 confocal microscope
equipped with an Olympus Cellcubator (Olympus). A 100×/1.4 oil immersion lens and
Fluoview software v1.7b were used. Cells were viewed using a 488 nm (GFP and DIC)
laser lines. Data was analysed and processed using Imaris 6.2.0 Software.

For photobleaching and photoconversions, cells from the parasite culture were arrested
on the glass bottom of a sterile, uncoated, hydrophobic 35 mm µ-Dish (Ibidi) using 0.5
mg per ml concanavalin A (Sigma) dissolved in distilled water. Concanavalin A was
added to the glass surface for 10 min and washed off using PBS. The P. falciparum
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culture was resuspended in PBS and allowed to settle on the dish for 5 minutes. PBS was
then used to wash off unbound cells and 37 °C phenol red-free culture medium
(Gilberger lab) was added to the dish. Cells were viewed using confocal microscopy at
37°C. The multiarea time-lapse function of the Fluoview software and a motorized stage
were used to observe multiple areas during each imaging experiment. The Olympus ZDC
autofocus system was used to ensure stacks were always imaged at the same position.
Image collection parameters were generally a 4 µs dwell time, 16–32 z-stacks (0.2–0.4
µm step size), a zoom level of 1–7 and laser levels of 0.1–3% for the 488 nm.

Photobleaching in Sec13pGFP-expressing cells was achieved using the 488nm laser with
85% intensity for a 0.5 second dwell time restricted to the area containing ERES of
interest. Generally, cells were subjected to only one beam of photobleaching. Cells were
then observed as previously described.

Green to red photoconversion in Sec13pDendra-expressing cells was achieved using
2,000µs dwell time of the 405 nm laser with 0.03% intensity restricted to the area
containing ERES of interest. Cells were then observed as previously described.
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Results
Analyzing ERES Recruitment
The existing cell line Sec13p-GFP (courtesy of S. Herrmann) was thawed and imaged
using fluorescence microscopy to confirm the expected morphology for Sec13p, a COPII
vesicle component and ERES marker, was present (Fig 1).

Figure 1. Localization of Sec13p-GFP. Unfixed parasites were stained with DAPI to
mark the nucleus and imaged using fluorescence microscopy. There is a single focus of
GFP signal, indicating an ERES, in a free merozoite overlying an uninfected RBC (a).
Ring form parasites of a doubly infected cell (b) show the GFP focus duplicates prior to
nuclear division. As the parasite matures from trophozoite stage (c) to schizont (d) the
ERES continue to multiply until each forming merozoite is associated one ERES.
Number of iRBCs imaged = 100.
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Z-stack images of unfixed Sec13p-GFP parasites in all stages were obtained using
confocal microscopy and reconstructed into 3D movies using Imaris software (Fig 2,
additional data not shown). These images confirmed fluorescence microscopy images
showing Sec13p is tightly compartmentalized near the nucleus. The signal duplicates
prior to nuclear division in ring form parasites and continues to multiply until each
progeny is associated with one focus of signal, indicating one ERES. No other foci of
Sec13p are seen in iRBCs.

Figure 2. Sec13p-GFP 3D reconstruction. Representative stills from movie showing
localization of ERES in three dimensions in a schizont stage parasite. Blue DAPI signal
indicates nucleus. GFP signal was noted to be tightly compartmentalized to one ERES
per nucleus of the maturing progeny. Size bar indicates 3µm. Number of iRBCs imaged =
20.
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After confirming localization of Sec13p-GFP, photobleaching using an argon laser with
488nm illumination was attempted. It was possible to photobleach individual ERES
without bleaching neighboring ERES (Fig 3). To ensure the ERES was fully bleached, Z
stacks of each parasite were taken to check that signal was eliminated at all 3D levels
within the iRBC. All schizont stage parasites photobleached were imaged until the iRBC
burst and free merozoites infected a neighboring RBC. This ensured the iRBCs remained
viable after photobleaching. The time to GFP signal recovery was found to be 15.2±2.8
seconds (Fig 4). All iRBCs photobleached recovered GFP signal. This information will
be utilized further in FLIP (Fluorescence Loss In Photobleaching) and FRAP
(Fluorescence Recovery After Photobleaching) experiments in the future.

Figure 3. Sec13p-GFP Photobleaching.
Representative image from Z stack of an iRBC with
GFP signal indicating ERES. White arrow indicates
area of isolated ERES prebleach (a) and post bleach
(b). Size bar indicates 0.5µm. Number of iRBCs
bleached = 20.

Figure 4. Time to GFP
signal recovery in photobleached Sec13p-GFP
parasites. Each blue dot
indicates an iRBC that was
photobleached. Red dot
indicates mean time to
signal recovery of 15.2
seconds
with
standard
deviation of ± 2.8 seconds.
Number of iRBCs photobleached = 20.
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Creating Dendra Constructs
The photobleaching of Sec13p-GFP parasites established that ERES can be individually
targeted via confocal microscopy lasers. To further analyze biogenesis of ERES, the cell
line Sec13p-Dendra was created. This utilized Dendra2, a green-to-red photoconvertible
protein. Sec13p-Dendra demonstrated proper localization to ERES (Fig 5), matching that
of Sec13p-GFP. This indicated the Dendra tag did not affect trafficking of Sec13p.

Figure 5. Localization of Sec13p-Dendra. Unfixed parasites were stained with DAPI to
mark the nucleus and imaged using fluorescence microscopy. There is a single focus of
unconverted Dendra signal, indicating an ERES, in a free merozoite overlying an
uninfected RBC (a). Young ring form parasites of a triply infected cell (b) show an
identical Dendra focus, which duplicates later in ring stage (c) prior to nuclear division.
As the parasite matures into a schizont (d) the ERES continue to multiply until each
forming merozoite is associated one ERES. Number of iRBCs imaged = 100.
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Since there is no commercially available Sec13p antibody to utilize in western blot
confirmation of the construct, further imaging was done to ensure proper positioning of
Sec13p-Dendra within the parasite. An immunofluorescence assay with α-BiP, an ER
marker, showed Sec13p-Dendra localizes to a tight compartment closely associated with
both the nucleus and the ER (Fig 6). This morphology was expected, as it was previously
noted for the cell line Sec13p-GFP (data not shown).

Figure 6. Sec13p-Dendra immunofluorescence assay with α-BiP. Fixed parasites were
stained with DAPI to mark the nucleus and imaged using fluorescence microscopy.
Unconverted Dendra signal, marking ERES, localizes to a compartment of the cell in
close relationship to the nucleus and the ER, marked by α-BiP. Number of cells imaged =
20, experiment repeated 3x.
After the Dendra2 tag was confirmed to have no alteration on Sec13p trafficking
throughout the parasite intraerythrocytic cycle, this technology was extended to create
two additional cell lines: Grasp1-Dendra and Grasp2-Dendra. These lines would allow
for the examination of Golgi biogenesis. Both Grasp1-Dendra (Fig 7) and Grasp2-Dendra
(Fig 8) localized to the expected, tightly-defined compartment in close association with
the nucleus. The localization pattern is virtually indistinguishable from that of Sec13p.
An α-Grasp western blot (Fig 9) confirmed both Grasp1-Dendra and Grasp2-Dendra
contained Grasp at the expected size of approximately 70kDa, with Grasp1-Dendra
containing two bands secondary to a known splicing event.
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Figure 7. Localization of Grasp1-Dendra. Unfixed parasites were stained with DAPI to
mark the nucleus and imaged using fluorescence microscopy. There is a single focus of
unconverted Dendra signal, indicating a Golgi, in a young ring stage parasite (a). This
focus doubles prior to nuclear division, which takes place in the trophozoite stage (b). As
the parasite matures into a schizont (c) the Golgi continue to multiply until each forming
merozoite is associated one Golgi. Number of iRBCs imaged = 100.

Figure 8. Localization of Grasp2-Dendra. Unfixed parasites were stained with DAPI to
mark the nucleus and imaged using fluorescence microscopy. A trophozoite stage
parasite (a) shows two foci of unconverted Dendra signal associated with each dividing
nucleus. Free merozoites from a recently burst iRBC (b) display one focus of signal,
representing a Golgi, associated with each progeny. Number of iRBCs imaged = 100.
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Figure 9. Grasp1-Dendra and Grasp2-Dendra construct
confirmation via αGrasp western blot. Lane one (left) shows
Grasp2 Dendra containing Grasp at approximately 70kDa. Lane two
shows Grasp1 Dendra containing two bands of Grasp, secondary to a
known splicing event, at approximately 70kDa. Experiment repeated
3x.

Dendra Photoconversions
After the creation and confirmation of the constructs Sec13p-Dendra, Grasp1-Dendra,
and Grasp2-Dendra, photoconversion (an irreversible change from green signal to a
stable red signal upon excitation) was attempted with the 405nm laser of a confocal
microscope. Unfortunately, the unconverted (green) signal from both Grasp1-Dendra and
Grasp2-Dendra were too weak to proceed with photoconversions (data not shown). The
signal from Sec13p-Dendra was considerably more intense and photoconversion was
possible (Fig 10). Individual ERES could be targeted without affecting neighboring
ERES. Full Z stacks of each photobleached parasite were inspected to ensure the ERES
was fully converted to red signal in all 3D levels of the iRBC. Schizont stage parasites
were followed until iRBCs burst and free merozoites infected neighboring cells, to ensure
parasite viability after photoconversion. It was possible to fully photoconvert 20/20
ERES targeted.
Figure 10. Sec13p-Dendra photoconversion.
Representative image from Z stack of an iRBC
containing a schizont stage parasite imaged with
confocal microscopy pre-conversion (a) and
immediately post-conversion (b). Full conversion of
the ERES indicated by the green arrow from a green
signal to red signal, indicated by red arrow, was possible without affecting surrounding
ERES. Size bar indicates 1µm. Number of iRBCs photoconverted = 20.
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To better understand ERES biogenesis, ring form parasites were targeted for Sec13p
photoconversion, since this is the stage at which ERES are known to duplicate prior to
nuclear division. 10 ring form parasites were targeted for photoconversion of the single
ERES present (Fig 11). These iRBCs were followed until the formation of a second
ERES was seen. In 10/10 parasites, the second ERES was found to contain only
unconverted, green Sec13p signal. This indicated the second ERES did not arise from a
splitting of the first, which would have resulted in a second ERES containing red,
converted Sec13p signal. The evidence suggests the second ERES formed de novo. In
zoomed projections of 3D images examining the components of converted and
unconverted Sec13p (Fig 12), it is found that new Sec13p is shuttled into the primary
ERES by 30 seconds post-photoconversion. This amount of new Sec13p protein increases
over time. At the point of new ERES development (Fig 12, 150 seconds postphotoconverison), only green, unconverted signal was observed. Within 30 seconds, red,
converted signal was seen within the new ERES. In addition, green, unconverted signal in
the old ERES was greatly increased. This is attributed to significant, rapid shuttling of
proteins between the two ERES.

Figure 11. New ERES formation. Representative image from a Z stack of an iRBC
containing a young ring form Sec13p-Dendra parasite imaged with confocal microscopy
pre-photoconversion (a), immediately post-conversion (b), 30 seconds post-conversion
(c), 60 seconds post-conversion (d), and 90 seconds post-conversion (e). A new ERES,
indicated by a green arrow (e), was found to have only green, unconverted signal. Size
bar indicates 2µm. This phenomenon was visualized in 10/10 ring form parasites
photoconverted.
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Figure 12. Protein trafficking between ERES. Representative images from Z stacks of
a ring form Sec13p-Dendra parasite imaged using confocal microscopy prephotoconversion, immediately post-photoconversion, and at 30 second intervals
thereafter. Boxed insets display zoomed images of 3D projections of Sec13p-Dendra
unconverted and converted protein contributing to merged images. At 30 seconds postconversion, unconverted Dendra signal is visible, indicating new protein being shuttled
into the existing ERES. The second ERES, visible at 150 seconds post-conversion
displays only unconverted signal, indicating it did not arise from a splitting of the first
ERES. By 180 seconds post-conversion, the new ERES displays converted signal,
indicating crosstalk from the old ERES. This phenomenon was visible in 10/10 ring form
parasites photoconverted.
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Investigating GRASP

The previous experiments gathered information on how ERES form. Although ERES
biogenesis is closely associated with Golgi biogenesis, it is difficult to draw conclusions
on how Golgi form without having a cell line that can be imaged in 4D. Since Grasp1Dendra and Grasp2-Dendra did not have strong enough signals for photoconversions that
could be watched over time, a new approach, involving the conditional degradation of
Grasp1 and Grasp 2 was attempted. The constructs Grasp1-DD and Grasp2-DD, along
with the similar constructs Grasp1-GFPDD and Grasp2-GFPDD, which utilized a GFP
tag for imaging, were created. All four utilized DD, a destabilizing domain, which
requires the ligand Shield 1 to allow for stable accumulations of the targeted protein, and
results in targeted degradation in its absence. To ensure the DD tag (in the presence of
Shield 1) was correctly inserted, Chelex pcr was performed on all four constructs (Fig
13). This technique took purified parasite lysate from each cell line, amplified the insert,
and sent the insert for sequencing. After amplification, Grasp1-DD and Grasp2-DD (Fig
13a) were found to have inserts of the expected approximately 350bp, which were
confirmed by sequencing to have 100% sequence similarity compared to DD’s known
sequence. Likewise, amplification of Grasp1-GFPDD and Grasp2-GFPDD (Fig 13b)
were found to have inserts of the expected approximately 1050bp, which also had 100%
sequence similarity compared to GFPDD’s known sequence. The constructs Grasp1-DD
and Grasp2-DD were further examined by α-Grasp western blot for the presence of
Grasp, to ensure there was no alteration caused by the DD tag in the presence of Shield 1
(Fig 14). The expected Grasp band at approximately 70kDa was seen for both constructs,
with an extra band noted for Grasp 1, secondary to a known splicing event.
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Figure 13. Grasp1/2-DD and Grasp1/2-GFPDD construct confirmation via Chelex
PCR. Parasite lysate from the cell lines Grasp1-DD and Grasp 2-DD (a), or Grasp1GFPDD and Grasp2-GFPDD (b), all cultured in the presence of Shield-1, were prepared
for chelex pcr using primers to amplify DD (a) or GFPDD (b). A band of approximately
350kb, corresponding to the size of DD, was seen for both Grasp1-DD and Grasp2-DD
(a). A band of approximately 1050kb, corresponding to the size of GFPDD, was seen for
both Grasp1-GFPDD and Grasp2-GFPDD (b). Experiment repeated 3x.

Figure 14. Grasp1-DD and Grasp2-DD construct
confirmation via αGrasp western blot. Pellets were prepared
from parasites cultured in the presence of Shield-1. Lane one
(left) shows Grasp1-DD containing two bands of Grasp,
secondary to a known splicing event, at approximately 70kDa.
Lane two (middle) shows Grasp2-DD containing Grasp at
approximately 70kDa. Lane 3 (right) shows 3D7 WT parasites
containing native Grasp at approximately 70kDa. Experiment
repeated 3x.

Imaging of the constructs Grasp1-GFPDD and Grasp2-GFPDD were done to check for
localization of Grasp (Fig 15). Grasp1-GFPDD was not found to have signal in close
association with the nucleus; the signal was still tightly compartmentalized, but
improperly targeted. Grasp2-GFPDD was found to have proper signal targeting in close
association with the nucleus, however there was a significant portion localizing to the
cytoplasm that inhibits further study. In addition, all four lines (Grasp1 or 2-DD and
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Grasp1 or 2-GFPDD) were also initially transfected without Shield1, which should have
either eliminated Grasp by targeting it for degradation or prevented the parasites from
growing altogether, if Grasp was an essential protein. All four cell lines without Shield 1
produced viable parasites, with Grasp still present and microscopic phenotypes for the
GFPDD lines identical to those grown in the presence of Shield 1 (data not shown). This
was suggestive of improper regulation of the DD system.

Figure 15. Localization of Grasp1-GFPDD and Grasp2-GFPDD. Unfixed parasites
were stained with DAPI to mark the nucleus and imaged using fluorescence microscopy.
Grasp1-GFPDD parasites (a) displayed improper targeting, with Golgi signal seen at a
distance from the nucleus, in a pattern suggesting Mauer’s cleft localization. Grasp2GFPDD parasites (b) display proper localization with one Golgi signal associated with
each forming merozoite in this schizont stage parasite, however a large cytosolic pool is
also present. Number of iRBCs imaged = 100.

To further regulate the DD system, a new conditional Grasp knock-out construct was
created by inserting the last 1000bp of Grasp1 fused to the DD tag into the pHCAM
knock-out vector that allows integration into the parasite DNA via single crossover
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recombination (Fig 16a). A triple hemagluttinin tag was added to aid in the purification
of GRASP interaction partners. Their subsequent identification will be achieved by mass
spectrometry. The proper Grasp1 (last 1000bp)-DD insert of approximately 1300kb was
identified following PstI/NheI digestion (Fig 16b). This construct was transfected into
parasites and will be analyzed once resistant parasites emerge.

Figure 16. Grasp1 knock-out construction. The last 1000bp of Grasp1 along with the
destabilization domain (DD) were cloned into the pHCAM knockout vector (a). The
location of Grasp1-DD is indicated by the tan bar, the triple hemagluttinin tag is indicated
by the purple bar. The restriction enzymes used for cloning, PstI and NheI, are indicated
by red asterisks. Grasp1-DDpHCAM3xHA plasmid confirmation via PstI/NheI digestion
is shown in (b). Plasmid DNA was purified and double digested. A band of
approximately 1300kb, corresponding to the size of Grasp1(last 1000bp)DD, is visible.
An upper band representing the remaining vector is also noted. Experiment repeated 3x.

To analyze Grasp interaction partners via a second approach, Grasp1 was fused to Tap
Tag to allow for tandem affinity purification of Grasp and its interaction partners, which
could further be investigated by SDS page analysis. An α-Grasp western blot was used to
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confirm the presence of Grasp in the construct, seen as a band of approximately 70kDa
(Fig 17). Three unknown additional bands of lower sizes were also seen. Tandem affinity
purification methods are currently being adjusted to allow for additional product yield
prior to SDS page analysis.

Figure 17. Grasp1-Tap Tag construct confirmation via αGrasp
western blot. Lane one (left) shows Grasp1-Tap Tag with a faint
band at approximately 70kDa, corresponding to Grasp. This band
runs at the same length as the native Grasp band seen in lane two
(right), at approximately 70kDa. Source of additional bands is
unknown. Experiment repeated 3x.

Discussion

Plasmodium falciparum is the culprit behind the most severe form of human malaria,
with over 200 million cases worldwide in 20097. Although the asexual, blood stage of the
parasite life cycle causes symptoms of the disease and is the target of nearly all available
antimalarials, relatively little is known about the secretory pathway that manages to
transport proteins to specialized parasite organelles and also into the host cell,
refurbishing the infected red blood cell to the parasite’s specifications. This thesis
examined the biogenesis of two critical organelles within P. falciparum’s secretory
pathway: endoplasmic reticulum exit sites (ERES) and the Golgi apparatus. This
examination was undertaken via the cloning of parasites containing fluorescently-labeled
proteins to identify ERES and the Golgi apparatus, namely Sec13p and GRASP,
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respectively. Time lapse 3D microscopy, photobleaching and photoconversions were
used to visualize the process. In addition, a more detailed understanding of GRASP in
relation to the Golgi was attempted via conditional knock-out of the protein.

ERES Dynamics in Plasmodium falciparum

To visualize ERES in P. falciparum, the COPII vesicle component and ERES marker
Sec13p was used. The existing parasite line Sec13p-GFP, containing the Sec13p protein
fused to a green fluorescent protein reporter was analyzed via fluorescent microscopy and
time-lapse 3D confocal microscopy (Figures 1 and 2). As previously reported in the
literature36, a phenotype of one ERES per parasite was seen in early stages, followed by
ERES duplication prior to nuclear division. Duplication continued until each forming
merozoite was associated with one ERES. In support of previous findings, the ERES
were found to be stable and relatively immobile when imaged with time-lapse
microscopy72,73.

To examine recruitment of the protein Sec13p to the ERES, individual ERES were
photobleached and the time to maximal fluorescence recovery was recorded (Figures 3
and 4). This technique has previously been employed to examine rhoptry protein
trafficking in P. falciparum74. Time to complete signal recovery was found to be 15.2
±2.8 seconds. A study performed in vero cells using photobleaching showed the time to
half maximal signal recovery for the COPII vesicle components Sar1p, Sec23p, and
Sec24p was 1.1sec, 3.7sec, and 3.9 sec respectively; data on Sec13p or time to maximal
recovery of signal was not available75. The finding for P. falciparum Sec13p time to
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recruitment is somewhat slower than that study, but may reflect differences in cargo
needs of the parasite, which may influence time to COPII vesicle component recruitment.
Nevertheless, it is clear that Sec13p is rapidly recruited to ERES in P. falciparum and
further mathematical analysis of available data with fluorescence recovery after
photobleaching and fluorescence loss in photobleaching projections may prove
recruitment was faster than first observed.

ERES and Golgi Biogenesis in Plasmodium falciparum

To examine how ERES and the Golgi form in P. falciparum, constructs fusing Dendra (a
green-to-red photoconvertible protein recently used to examine the Maurer’s cleft protein
REX2 with time-lapse microscopy in P. falciparum76) to the protein Sec13p for ERES
visualization or GRASP1 or GRASP2 for Golgi visualization were created. The construct
Sec13pDendra localized properly and was further confirmed with an α-BiP
immunofluorescence assay, showing the relationship between the ER and ERES (Figures
5 and 6). The constructs GRASP1Dendra and GRASP2Dendra also possessed proper
localization and were confirmed with α-GRASP western blots (Figures 7, 8 and 9).

However, GRASP1Dendra and GRASP2Dendra displayed a fluorescence signal too
weak to be used for time-lapse confocal microscopy and photoconversions. Attempts
were made to increase the selection pressure with additional WR 99210 to eliminate any
wild-type parasites that may have been present following transfection, however it was not
possible to bring fluorescence to the level needed for further direct experiments on Golgi
biogenesis. The constructs GRASP1Dendra and GRASP2Dendra have been re-
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transfected into wild type parasites and should be re-analyzed for appropriate signal once
selection is achieved.

Sec13pDendra did have a strong enough fluorescent signal to continue with
photoconversions, and it was possible to fully photoconvert individual ERES from green
uncoverted signal to red converted signal in parasites of all stages, in addition
neighboring ERES in late-stage parasites were not affected (Figure 10). To ensure full
conversion took place, infected red blood cells were imaged in 3D to examine the signal
from all angles. Young ring-stage parasites that were followed until duplication of the
initial singular ERES was seen were all found to display only green, unconverted signal
in the new ERES (Fig 11). This indicates the ERES did not split, which would have
resulted in red converted signal or a mix of red and green signal. This is in line with
findings seen in Pichia pastoris and Trypanosoma brucei, where ERES formed de novo
and were also associated with the de novo formation of the adjacent Golgi apparatus43, 44,
77

. Although conclusions on Golgi biogenesis can not be drawn without direct

visualization of the apparatus, it can be speculated that Golgi formation closely follows
ERES formation in P. falciparum, especially due to the close proximity and near identical
timing of duplication for ERES and the Golgi within the P. falciparum life cycle, shifting
the evidence towards likely de novo formation of the Golgi apparatus.

Protein trafficking was also visualized between ERES (Figure 12). Both converted and
unconverted Sec13pDendra signal was seen in both ERES as soon as 30 seconds after the
formation of the new ERES. This indicates the protein was shuttled between the two
locations, possibly to accommodate for extra transport necessary as the cell was about to

43
undergo nuclear division. Timing of protein transport was in line with that of ERES
recruitment seen in previous photobleaching experiments described above.

GRASP Examination in Plasmodium falciparum

The role of GRASP, a Golgi marker known to be anchored to the Golgi membrane and
involved in the structural architecture of the organelle46, is of particular interest in P.
falciparum since it possesses two variants of the gene in spite of a simple-appearing,
unstacked Golgi42. The protein’s postulated role in alternative secretion of proteins50,51
makes it an interesting knock-out candidate to examine the effects on P. falciparum Golgi
architecture and protein export.

At first, a conditional knock-out of GRASP was attempted by fusing GRASP1 and
GRASP2, both with and without a green fluorescent protein reporter to a destabilization
domain (DD). This domain was developed as a technique to regulate protein amounts in
P. falciparum, an organism that lacks RNAi machinery, by allowing stable accumulation
of the protein in the presence of the ligand Shld 1 and protein target for destruction in the
absence

of

the

ligand78.

The

four

constructs

GRASP1DD,

GRASP2DD,

GRASP1GFPDD and GRASP2GFPDD were confirmed with chelex PCR (Figure 13). In
addition, GRASP1DD and GRASP2DD were further confirmed with α-GRASP western
blots (Figure 14). As a control, parasite transfections were all split into two dishes, one
with Shld1 and one without Shld1. All transfectants, with and without Shld1 were viable
after selection. However, imaging of parasites containing the GFP reporter (Figure 15)
showed improper targeting, resembling that of Maurer’s cleft targeting for
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GRASP1GFPDD. GRASP2GFPDD showed proper targeting to the Golgi, but the
background cytosolic pool of the protein was too great to continue with further imaging
or analysis. The presence of viable parasites grown in the absence of Shld1, where
GRASP should have been degraded, may indicate GRASP is not essential in P.
falciparum Golgi formation, given that Golgi were still visualized. However, the lack of a
difference in imaging between the groups grown with and without Shld1 likely suggests
the DD system was not closely regulated. If proteins were not properly degraded,
conclusions on GRASP importance cannot be drawn. Further experiments on DD
parameters regulation are currently underway in this laboratory. This may allow more
evidence to be gathered once the ideal concentrations of Shld1 in which to grow the
parasites and the appropriate timing of Shld1 removal are uncovered.

Meanwhile a more stable method of GRASP degredation was begun, by introducing the
last 1000bp of GRASP1, fused to DD into the knock-out vector pHCAM3xHA (Figure
16). This will integrate the insert into the parasite DNA, allowing for a more stable
knock-out line, and the presence of a hemagluttinin tag will allow for purification of
GRASP interaction partners with subsequent identification via mass spectrometry. These
parasites have passed through selection and will be analyzed once the ideal parameters
for DD within this laboratory setting are determined. However, if the DD system is not
working properly, this construct will also find the issues previously described for the
GRASPDD contructs.

Finally, as another method of beginning to examine the interaction partners of GRASP,
of particular interest in the realm of alternative secretion of proteins, GRASP1 was fused
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to a tandem affinity purification (TAP) tag. The TAP tag consists of ProtA (two IgG
binding units for Protein A derived from Staphylococcus aureus), TEV (a tobacco etch
virus cleavage site) and CBP (a calmodulin binding domain); it is fused to the protein of
interest79. To analyze the complex, as has been done to identify interaction partners for
the P. falciparum Translation Elongation Factor complex80, parasite lysate containing the
protein complex is attached to an IgG matrix by the TAP tag ProtA, this is then eluted
with TEV protease, incubated with calmodulin-coated beads in the presence of calcium,
washed and eluted with EGTA79. So far, the desired construct has been created,
transfected, selected and confirmed via α-GRASP western blot (Figure 17). The western
blot did display additional bands below that expected for GRASP, which could represent
some protein degradation or problem with the parasite lysate. Optimization of the
purification steps is being done, as product yield was not sufficient in preliminary
attempts. A possible issue is the interaction of some endogenous proteins with the CBP
portion of the TAP tag, which has been troubleshooted in the past by replacing the CBP
with another tag, such as ProtC79.

Conclusions

In this thesis, it was shown that Plasmodium falciparum ERES, as visualized by the
COPII vesicle component Sec13p, undergo recruitment at rapid rates of approximately
15.2 seconds following photobleaching experiments. Evidence gathered via time-lapse
microscopy in conjunction with photoconversions of Sec13p fused to Dendra showed that
ERES form de novo and not by fission. Although conclusive evidence on Golgi
biogenesis was not obtained, given the close spatial and duplication time relationship
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between ERES and the Golgi in P. falciparum, in addition to past studies performed in P.
pastoris and T. brucei, it is speculated that the P. falciparum Golgi similarly forms de
novo. Strides were made towards the creation of a GRASP knock-out and examination of
GRASP interaction partners in P. falciparum, which after optimization of methods, may
allow for a more detailed study of Golgi biogenesis, GRASP effect on Golgi architecture
and on alternative secretion of proteins. The implications of this research are to improve
the understanding of the P. falciparum secretory pathway, which may lead to easier
selection of parasite drug targets in the fight against malaria.
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